Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, December 2, 2022
[ Fri, Dec 02nd 2022
] - WOPRAI
[ Fri, Dec 02nd 2022
] - WOPRAI
[ Fri, Dec 02nd 2022
] - WOPRAI
[ Fri, Dec 02nd 2022
] - WOPRAI
[ Fri, Dec 02nd 2022
] - WOPRAI
[ Fri, Dec 02nd 2022
] - WOPRAI
[ Fri, Dec 02nd 2022
] - WOPRAI
[ Fri, Dec 02nd 2022
] - WOPRAI
[ Fri, Dec 02nd 2022
] - WOPRAI
[ Fri, Dec 02nd 2022
] - WOPRAI
Thu, December 1, 2022
[ Thu, Dec 01st 2022
] - WOPRAI
[ Thu, Dec 01st 2022
] - WOPRAI
[ Thu, Dec 01st 2022
] - WOPRAI
[ Thu, Dec 01st 2022
] - WOPRAI
[ Thu, Dec 01st 2022
] - WOPRAI
[ Thu, Dec 01st 2022
] - WOPRAI
[ Thu, Dec 01st 2022
] - WOPRAI
[ Thu, Dec 01st 2022
] - WOPRAI
[ Thu, Dec 01st 2022
] - WOPRAI
[ Thu, Dec 01st 2022
] - WOPRAI
[ Thu, Dec 01st 2022
] - WOPRAI
[ Thu, Dec 01st 2022
] - WOPRAI
[ Thu, Dec 01st 2022
] - WOPRAI
[ Thu, Dec 01st 2022
] - WOPRAI
[ Thu, Dec 01st 2022
] - WOPRAI
[ Thu, Dec 01st 2022
] - WOPRAI
[ Thu, Dec 01st 2022
] - WOPRAI
[ Thu, Dec 01st 2022
] - WOPRAI
[ Thu, Dec 01st 2022
] - WOPRAI
Alec Stranahan Initiated (SWTX) at Strong Buy and Held Target at $45 on, Dec 1st, 2022
Alec Stranahan of B of A Securities, Initiated "SpringWorks Therapeutics, Inc." (SWTX) at Strong Buy and Held Target at $45 on, Dec 1st, 2022.
Alec has made no other calls on SWTX in the last 4 months.
There are 2 other peers that have a rating on SWTX. Out of the 2 peers that are also analyzing SWTX, 0 agree with Alec's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Alec
- Robert Burns of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $99 on, Friday, November 4th, 2022
- Corinne Jenkins of "Goldman Sachs" Maintained at Strong Buy with Decreased Target to $44 on, Friday, October 21st, 2022
